Cytoskeletal restraints regulate homotypic ALCAM-mediated adhesion through PKCalpha independently of Rho-like GTPases.
The activated leukocyte cell adhesion molecule (ALCAM) is dynamically regulated by the actin cytoskeleton. In this study we explored the molecular mechanisms and signaling pathways underlying the cytoskeletal restraints of this homotypic adhesion molecule. We observed that ALCAM-mediated adhesion induced by cytoskeleton-disrupting agents is accompanied by activation of the small GTPases RhoA, Rac1 and Cdc42. Interestingly, unlike adhesion mediated by integrins or cadherins, ALCAM-mediated adhesion appears to be independent of Rho-like GTPase activity. By contrast, we demonstrated that protein kinase C (PKC) plays a major role in ALCAM-mediated adhesion. PKC inhibition by chelerythrine chloride and myristoylated PKC pseudosubstrate, as well as PKC downregulation by PMA strongly reduce cytoskeleton-dependent ALCAM-mediated adhesion. Since serine and threonine residues are dispensable for ALCAM-mediated adhesion and ALCAM is not phosphorylated, we can rule out that ALCAM itself is a direct PKC substrate. We conclude that PKCalpha plays a dominant role in cytoskeleton-dependent avidity modulation of ALCAM.
Zimmerman
Aukje W
AW
Department of Tumor Immunology, University Medical Center St Radboud, Nijmegen, The Netherlands.
Nelissen
Judith M D T
JM
van Emst-de Vries
Sjenet E
SE
Willems
Peter H G M
PH
de Lange
Frank
F
Collard
John G
JG
van Leeuwen
Frank N
FN
Figdor
Carl G
CG
D020410:Activated-Leukocyte Cell Adhesion Molecule / Q000235:genetics / Q000378:metabolism*; D000470:Alkaloids; D000911:Antibodies, Monoclonal / Q000378:metabolism; D053119:Benzophenanthridines; D015153:Blotting, Western; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000494:pharmacology; D002448:Cell Adhesion / Q000187:drug effects*; D015638:Cytochalasin D / Q000494:pharmacology; D003599:Cytoskeleton / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D015536:Down-Regulation; D016650:Fluorescein-5-isothiocyanate; D005456:Fluorescent Dyes; D006801:Humans; D020014:K562 Cells; D008856:Microscopy, Fluorescence; D010617:Phenanthridines / Q000494:pharmacology; D010761:Phosphorus Radioisotopes; D011493:Protein Kinase C / Q000187:drug effects / Q000378:metabolism*; D051571:Protein Kinase C-alpha; D012190:Retroviridae / Q000235:genetics; D013379:Substrate Specificity; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D013844:Thiazoles / Q000494:pharmacology; D053778:Thiazolidines; D020741:rho GTP-Binding Proteins / Q000378:metabolism*
D020410:Activated-Leukocyte Cell Adhesion Molecule; D000470:Alkaloids; D000911:Antibodies, Monoclonal; D053119:Benzophenanthridines; D019086:Bridged Bicyclo Compounds, Heterocyclic; D005456:Fluorescent Dyes; D010617:Phenanthridines; D010761:Phosphorus Radioisotopes; D013844:Thiazoles; D053778:Thiazolidines; D015638:Cytochalasin D; C016299:chelerythrine; C496628:PRKCA protein, human; D011493:Protein Kinase C; D051571:Protein Kinase C-alpha; D020741:rho GTP-Binding Proteins; D016650:Fluorescein-5-isothiocyanate; D013755:Tetradecanoylphorbol Acetate; C037067:latrunculin A